申请人:Rhone-Poulenc Rorer, S.A.
公开号:US05374656A1
公开(公告)日:1994-12-20
This invention relates to compounds of formula: ##STR1## in which R.sub.1 represents a hydrogen atom or an alkyl or alkoxycarbonyl radical or an unsubstituted or substituted phenyl radical, R.sub.2 represents an alkyl (1-8 C) or polyfluoroalkyl radical or an unsubstituted or substituted cycloalkyl radical, R.sub.3 represents an unsubstituted or substituted phenyl radical, a naphthyl, indolyl, quinolyl or phenylamino radical in which the phenyl ring is optionally substituted, or a quinolylamino radical, and m is 0 or 1, the process for preparing them and the medicaments containing them.
本发明涉及以下结构式的化合物:##STR1## 其中R.sub.1代表氢原子或烷基或烷氧基羰基基团或未取代或取代的苯基基团,R.sub.2代表烷基(1-8 C)或多氟烷基基团或未取代或取代的环烷基基团,R.sub.3代表未取代或取代的苯基基团,萘基,吲哚基,喹啉基或苯胺基基团,其中苯环可选取代,或喹啉胺基基团,m为0或1,以及制备它们和含有它们的药物的过程。